| Linden Family Medicine Clinic Llc | |
|
400 Hualani St Ste 196 Hilo HI 96720-4378 | |
| (808) 961-0146 | |
| (808) 969-3378 |
| Full Name | Linden Family Medicine Clinic Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 400 Hualani St, Hilo, Hawaii |
| Authorized Official Name and Position | Margaret Rosemary Linden (MANAGER/OWNER) |
| Authorized Official Contact | 8089610146 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Linden Family Medicine Clinic Llc 400 Hualani St Ste 196 Hilo HI 96720-4378 Ph: (808) 961-0146 | Linden Family Medicine Clinic Llc 400 Hualani St Ste 196 Hilo HI 96720-4378 Ph: (808) 961-0146 |
| NPI Number | 1780127225 |
|---|---|
| Provider Enumeration Date | 12/01/2016 |
| Last Update Date | 02/03/2017 |
| Medicare PECOS PAC ID | 3870877236 |
|---|---|
| Medicare Enrollment ID | O20170302000824 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780127225 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 363LF0000X | Nurse Practitioner - Family | (* (Not Available)) | Secondary |
| Provider Name | Gina Marie Salcedo |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1598803306 PECOS PAC ID: 7012167570 Enrollment ID: I20150624001011 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Provider Name | Hui Chen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104281757 PECOS PAC ID: 0648576215 Enrollment ID: I20160308000875 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Provider Name | Alin V Ledford |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1972716348 PECOS PAC ID: 1658522198 Enrollment ID: I20170523002360 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Provider Name | William Meeker |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720020761 PECOS PAC ID: 6406840875 Enrollment ID: I20181005002804 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Provider Name | Patrick W Young |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164879649 PECOS PAC ID: 7113218058 Enrollment ID: I20190225001178 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Provider Name | Laurence Eugene Badgley |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1477647287 PECOS PAC ID: 5698683381 Enrollment ID: I20190612001697 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
| Provider Name | Chad Lm Ahia |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1417593831 PECOS PAC ID: 7517333586 Enrollment ID: I20230120000385 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
News Archive
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
A couples' neglect of their child's health which resulted in "dire and tragic consequences" has earned them prison sentences.
The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.
Two international research studies, both led by investigators affiliated with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
› Verified 4 days ago
Rainbow Healthcare Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 E Lanikaula St, Hilo, HI 96720 Phone: 808-238-4922 | |
Carlos R. Abeyta Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 82 Puuhonu Pl, Suite 206, Hilo, HI 96720 Phone: 808-969-9888 Fax: 808-969-9881 | |
Joyful Living, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1248 Kinoole St, Suite 101, Hilo, HI 96720 Phone: 808-935-8398 | |
Administration Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 450 Kilauea Ave Ste 105, Hilo, HI 96720 Phone: 808-961-4071 Fax: 808-961-5678 | |
Craig Y. Shikuma, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 82 Puuhonu Pl, Suite 207, Hilo, HI 96720 Phone: 808-935-5522 Fax: 808-961-5058 | |
J Nohea Kaawaloa Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 670 Ponahawai St, Suite 220, Hilo, HI 96720 Phone: 808-933-1120 Fax: 808-933-1125 | |
Big Island Family Medicine Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St Ste 207, Hilo, HI 96720 Phone: 808-365-5988 Fax: 808-365-5989 |